Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. PharmaCyte Biotech ( (PMCB)) has issued ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Purple Biotech ( (PPBT)) just unveiled an ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Biotech company Amgen is investing $600 million into a new research center for its Thousand Oaks campus. The new site will create hundreds of jobs and feature advanced automation and digital ...
Albany, NY (WRGB) — Governor Hochul announced the formation of a new Emerging Technology Advisory Board focused on biotechnology, aimed at bolstering New York's status as a leader in life sciences and ...
Exelixis, a high-flying biotech company that creates anti-cancer drugs in Alameda, is laying off 130 workers. Exelixis had, like others in the industry, hired heavily during and after the pandemic, ...
‘Disheartening? Yes. Surprising? No.’ Report on the future of biotech in Mass. gives a grim outlook.
The industry group MassBio released its annual temperature check on the state’s biotech industry Tuesday, and the results are grim. Both public and private funding have plummeted as federal policy ...
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced the acquisition of Purvala Bioscience, a Boston-based biotech company.
Gene therapy biotech Kriya Therapeutics has secured $313 million in a new series fundraise. The private U.S. company disclosed the equity financing in a Securities and Exchange Commission document ...
Mr. Dreyer is an American editor and writer who lives in Shanghai. Just outside Shanghai, in the city of Wuxi, China is building its future of medicine — a booming biotechnology hub of factories and ...
He’s the anti-Mamdani. A Cuban-born biotech entrepreneur decided to make a longshot bid for NYC mayor because he loathes the radical left-wing ideas pushed by socialist frontrunner Zohran Mamdani — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback